CF
CLB icon

Corebridge Financial’s Core Laboratories CLB Stock Holding History

Corebridge Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,516
Closed -$367K – 562
2025
Q1 		$367K Sell
24,516
-484
-2% -$8.1K ﹤0.01% 1752
2024
Q4 		$433K Sell
25,000
-1,950
-7% -$37.6K ﹤0.01% 1759
2024
Q3 		$499K Sell
26,950
-285
-1% -$5.72K ﹤0.01% 1734
2024
Q2 		$553K Buy
+27,235
New +$482K ﹤0.01% 1643

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Corebridge Financial's CLB Position: Q2 2025 in Review

Corebridge Financial sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 24,516 shares — an estimated $367K sold.

Corebridge Financial first reported a position in CLB in Q2 2024 and held it in 4 quarters. The position peaked at $553K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • Corebridge Financial reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 24,516 Core Laboratories shares in Q2 2025, an estimated $367K.
  • Corebridge Financial first reported a position in Core Laboratories in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Core Laboratories position peaked at $553K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.